BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15

-Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced the initiation of a Phase 3 clinical study, Vacc...

August 09, 2022 | News

LG Chem Enters Final Stage of Clinical Development for New Gout Drug

In global Phase 3 clinical trial, Tigulixostat will be evaluated in 350 adult gout patients with hyperuricemia for safety and efficacy at Month 6 of treatm...

August 04, 2022 | News

Thermo Fisher Scientific Showcases New Clinical and Research Lab Solutions at AACC 2022

Thermo Fisher Scientific Inc., the world leader in serving science, is showcasing innovative diagnostic technologies, assays and a complement of solutions ...

July 26, 2022 | News

Ozgene and Gen-H partner on Ozgene’s new OzBIG targeted humanization capability

Ozgene and Gen-H are pleased to announce our working partnership supporting Ozgene’s new OzBIG capability. Ozgene Pty Ltd is a privately held CRO bas...

July 25, 2022 | News

Pulnovo Medical Concludes Successfully First Pre-Sub Meeting with FDA for PADN Global Clinical Trial

Dr. Shaoliang Chen, Chair of Pulnovo Medical's Scientific Advisory Board and pioneer of the PADN technology, attended the meeting and presented the co...

July 18, 2022 | News

Novotech Client SK bioscience Achieves SKYCovione(TM) COVID-19 Vaccine Approval in Korea

SK bioscience and GSK recently announced the successful authorization:SK bioscience announced that 'SKYCovione(TM),' South Korea's first COVID-19 vaccine c...

July 14, 2022 | News

WuXi XDC and AbTis Sign Memorandum of Understanding for Development and Manufacturing of Antibody Drug Conjugates

Under the partnership, AbTis will have access to WuXi XDC's integrated services for linker and payload manufacturing, ADC conjugation process developm...

July 08, 2022 | News

Clinical Trial Approval For mRNA Covid-19 Vaccine For Omicron Variant In The Philippines

R520A is an mRNA COVID-19 vaccine specifically targeting the Omicron variant developed by Wuhan Recogen Biotechnology Co., Ltd., a subsidiary of the Compan...

June 28, 2022 | News

Novotech and Medidata expand partnership to continue advancements in clinical research

Medidata, a Dassault Systèmes company, today announced its renewed, expanded partnership with Novotech, a leading contract research organisation (CR...

June 16, 2022 | News

I-Mab Reports Latest Phase 2 Clinical Data of its Differentiated CD73 Antibody Uliledlimab

Encouraging efficacy signals were observed in a non-small cell lung cancer (NSCLC) patient cohort - Results indicate CD73 expression corr...

May 27, 2022 | News

RhoVac AB announces Database Lock in its clinical phase IIb trial of onilcamotide

This means that all data from the trial is now finally reported, cleaned and "locked" in the data base. The next step will be analysis to produce the resul...

May 11, 2022 | News

SCG Cell Therapy announces HSA clinical trial approval of TCR-T cell therapy for liver cancer

SCG101 is the first TCR-T cell therapy product to receive a multi-regional Investigational New Drug (IND) approval from Singapore's Health Scie...

May 09, 2022 | News

Novotech Acquires US CRO NCGS, Expands Global Expertise

Novotech CEO Dr. John Moller said "We are very pleased to acquire such an impressive company with a strong history of quality and delivery in the United St...

May 05, 2022 | News

Inmagene Receives FDA's IND Clearance for OX40 Antagonist

IMG-007 is highly potent at blocking the binding of OX40 to OX40L, thereby reducing OX40L-dependent downstream signaling and cytokine release by T cells. I...

May 02, 2022 | News

Stay Connected